{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:52:56Z","timestamp":1785214376631,"version":"3.55.0"},"reference-count":61,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>There are currently no antiviral agents for human metapneumovirus (HMPV), respiratory syncytial virus (RSV), mumps virus (MuV), or measles virus (MeV). Favipiravir has been developed as an anti-influenza agent, and this agent may be effective against these viruses in vitro. However, the molecular mechanisms through which the agent affects virus replication remain to be fully elucidated. Thus, to clarify the detailed molecular interactions between favipiravir and the RNA-dependent RNA polymerase (RdRp) of HMPV, RSV, MuV, MeV, and influenza virus, we performed in silico studies using authentic bioinformatics technologies. As a result, we found that the active form of favipiravir (favipiravir ribofuranosyl-5\u2032-triphosphate [F-RTP]) can bind to the RdRp active sites of HMPV, RSV, MuV, and MeV. The aspartic acid residue of RdRp active sites was involved in the interaction. Moreover, F-RTP was incorporated into the growing viral RNA chain in the presence of nucleotide triphosphate and magnesium ions. The results suggested that favipiravir shows two distinct mechanisms in various viruses: RdRp active site inhibition and\/or genome replication inhibition.<\/jats:p>","DOI":"10.3390\/v14020338","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T20:36:42Z","timestamp":1644266202000},"page":"338","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Detailed Analyses of Molecular Interactions between Favipiravir and RNA Viruses In Silico"],"prefix":"10.3390","volume":"14","author":[{"given":"Tatsuya","family":"Shirai","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka-shi 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-8128","authenticated-orcid":false,"given":"Takeshi","family":"Saraya","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka-shi 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kurai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka-shi 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoka","family":"Sunagawa","sequence":"additional","affiliation":[{"name":"Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyuki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka-shi 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fmicb.2015.00517","article-title":"Broad-spectrum antiviral agents","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20587384211002621","DOI":"10.1177\/20587384211002621","article-title":"A review: Mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1021\/bi801179f","article-title":"DNA polymerases as therapeutic targets","volume":"47","author":"Berdis","year":"2008","journal-title":"Biochemistry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.idc.2017.05.004","article-title":"Severe respiratory viral Infections: New evidence and changing paradigms","volume":"31","author":"Walter","year":"2017","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4445","article-title":"Molecular biology, pathogenesis and pathology of mumps virus","volume":"235","author":"Rubin","year":"2015","journal-title":"J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2018.07.001","article-title":"Viral Encephalitis","volume":"36","author":"Venkatesan","year":"2018","journal-title":"Neurol. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antiviral. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2012.07.034","article-title":"Favipiravir (T-705) inhibits in vitro norovirus replication","volume":"424","author":"Jochmans","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/AAC.00709-16","article-title":"Antiviral activity of favipiravir (T-705) against a broad range of paramyxoviruses in vitro and against human metapneumovirus in hamsters","volume":"60","author":"Jochmans","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104849","DOI":"10.1016\/j.antiviral.2020.104849","article-title":"In vitro inhibition of mumps virus replication by favipiravir (T-705)","volume":"180","author":"Lawson","year":"2020","journal-title":"Antiviral. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pinzi, L., and Rastelli, G. (2019). Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184331"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov. Today."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cichero, E., Calautti, A., Francesconi, V., Tonelli, M., Schenone, S., and Fossa, P. (2021). Probing in silico the benzimidazole privileged scaffold for the development of drug-like anti-RSV agents. Pharmaceuticals, 14.","DOI":"10.3390\/ph14121307"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: A powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided. Drug Des."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cbdd.13388","article-title":"Homology modeling in drug discovery: Overview, current applications, and future perspectives","volume":"93","author":"Muhammed","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.ddtec.2012.07.009","article-title":"In silico virtual screening approaches for anti-viral drug discovery","volume":"9","author":"Murgueitio","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Francesconi, V., Cichero, E., Kanov, E.V., Laurini, E., Pricl, S., Gainetdinov, R.R., and Tonelli, M. (2020). Novel 1-amidino-4-phenylpiperazines as potent agonists at human TAAR1 receptor: Rational design, synthesis, biological evaluation and molecular docking studies. Pharmaceuticals, 13.","DOI":"10.3390\/ph13110391"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-019-1759-1","article-title":"Structure of the human metapneumovirus polymerase phosphoprotein complex","volume":"577","author":"Pan","year":"2020","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41467-019-14246-3","article-title":"Cryo-EM structure of the respiratory syncytial virus RNA polymerase","volume":"11","author":"Cao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"ref_27","first-page":"5.6.1","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Protein. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.jcim.6b00407","article-title":"MIB: Metal ion-binding site prediction and docking server","volume":"56","author":"Lin","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: A web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic. Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3389\/fmicb.2019.01490","article-title":"RNA synthesis and capping by non-segmented negative strand RNA viral polymerases: Lessons from a prototypic virus","volume":"10","author":"Ogino","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/jvi.68.3.1819-1826.1994","article-title":"Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1","volume":"68","author":"Biswas","year":"1994","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21401","article-title":"The influenza virus polymerase complex: An update on its structure, functions, and significance for antiviral drug design","volume":"36","author":"Stevaert","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2019.08.014","article-title":"Structure of the respiratory syncytial virus polymerase complex","volume":"179","author":"Gilman","year":"2019","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0042-6822(92)90555-4","article-title":"Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence","volume":"188","author":"Okazaki","year":"1992","journal-title":"Virology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sourimant, J., and Plemper, R.K. (2016). Organization, function, and therapeutic targeting of the morbillivirus RNA-dependent RNA polymerase complex. Viruses, 8.","DOI":"10.3390\/v8090251"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virusres.2003.11.003","article-title":"Effect of single amino acid mutations in the conserved GDNQ motif of L protein of Rinderpest virus on RNA synthesis in vitro and in vivo","volume":"99","author":"Chattopadhyay","year":"2004","journal-title":"Virus. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1073\/pnas.1919837117","article-title":"Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation","volume":"117","author":"Abdella","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41586-019-1530-7","article-title":"Structures of influenza A virus RNA polymerase offer insight into viral genome replication","volume":"573","author":"Fan","year":"2019","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-540-79086-0_3","article-title":"Antiviral agents acting as DNA or RNA chain terminators","volume":"189","author":"Neyts","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sada, M., Saraya, T., Ishii, H., Okayama, K., Hayashi, Y., Tsugawa, T., Nishina, A., Murakami, K., Kuroda, M., and Ryo, A. (2020). Detailed molecular interactions of favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza virus polymerases in silico. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101610"},{"key":"ref_49","first-page":"137","article-title":"Structure-function relationships among RNA-dependent RNA polymerases","volume":"320","author":"Ng","year":"2008","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11262-006-0001-z","article-title":"Mutational analysis of the GDD sequence motif of classical swine fever virus RNA-dependent RNA polymerases","volume":"34","author":"Wang","year":"2007","journal-title":"Virus Genes."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2021946118","DOI":"10.1073\/pnas.2021946118","article-title":"Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP","volume":"118","author":"Naydenova","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","first-page":"100080","article-title":"Structural basis of SARS-CoV-2 polymerase inhibition by favipiravir","volume":"2","author":"Peng","year":"2021","journal-title":"Innovation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez, D., and Caballero, J. (2018). Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?. Molecules, 23.","DOI":"10.3390\/molecules23051038"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jmb.2008.01.049","article-title":"Rescoring docking hit lists for model cavity sites: Predictions and experimental testing","volume":"377","author":"Graves","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/minf.201400132","article-title":"Improving AutoDock Vina using random forest: The growing accuracy of binding affinity prediction by the effective exploitation of larger data sets","volume":"34","author":"Li","year":"2015","journal-title":"Mol. Inform."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1021\/ci200377u","article-title":"Statistical potential for modeling and ranking of protein-ligand interactions","volume":"51","author":"Fan","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e00487-17","DOI":"10.1128\/JVI.00487-17","article-title":"Understanding the mechanism of the broad-spectrum antiviral activity of favipiravir (T-705): Key role of the F1 motif of the viral polymerase","volume":"91","author":"Abdelnabi","year":"2017","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.bpj.2021.07.026","article-title":"\u201cBucket brigade\u201d using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2","volume":"120","author":"Tanimoto","year":"2021","journal-title":"Biophys. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/acs.jcim.1c00380","article-title":"Large-scale membrane permeability prediction of cyclic peptides crossing a lipid bilayer based on enhanced sampling molecular dynamics simulations","volume":"61","author":"Sugita","year":"2021","journal-title":"J. Chem. Inf. Model."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/2\/338\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:15:46Z","timestamp":1760134546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/2\/338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["v14020338"],"URL":"https:\/\/doi.org\/10.3390\/v14020338","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}